204 related articles for article (PubMed ID: 8713779)
1. beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface.
Mori T; Takeya H; Nishioka J; Gabazza EC; Suzuki K
Thromb Haemost; 1996 Jan; 75(1):49-55. PubMed ID: 8713779
[TBL] [Abstract][Full Text] [Related]
2. Cardiolipin enhances protein C pathway anticoagulant activity.
Fernández JA; Kojima K; Petäjä J; Hackeng TM; Griffin JH
Blood Cells Mol Dis; 2000 Apr; 26(2):115-23. PubMed ID: 10753602
[TBL] [Abstract][Full Text] [Related]
3. Factor V and protein S as cofactors to activated protein C.
Dahlbäck B
Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
[TBL] [Abstract][Full Text] [Related]
4. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
5. A prothrombinase-based assay for detection of resistance to activated protein C.
Nicolaes GA; Thomassen MC; van Oerle R; Hamulyak K; Hemker HC; Tans G; Rosing J
Thromb Haemost; 1996 Sep; 76(3):404-10. PubMed ID: 8883278
[TBL] [Abstract][Full Text] [Related]
6. The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S.
van Wijnen M; Stam JG; van't Veer C; Meijers JC; Reitsma PH; Bertina RM; Bouma BN
Thromb Haemost; 1996 Sep; 76(3):397-403. PubMed ID: 8883277
[TBL] [Abstract][Full Text] [Related]
7. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
[TBL] [Abstract][Full Text] [Related]
8. Regulation of prothrombinase activity by protein S.
van 't Veer C; Butenas S; Golden NJ; Mann KG
Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
[TBL] [Abstract][Full Text] [Related]
9. C4b-binding protein inhibits the factor V-dependent but not the factor V-independent cofactor activity of protein S in the activated protein C-mediated inactivation of factor VIIIa.
van de Poel RH; Meijers JC; Bouma BN
Thromb Haemost; 2001 May; 85(5):761-5. PubMed ID: 11372664
[TBL] [Abstract][Full Text] [Related]
10. Human factor Va1 and factor Va2: properties in the procoagulant and anticoagulant pathways.
Hoekema L; Nicolaes GA; Hemker HC; Tans G; Rosing J
Biochemistry; 1997 Mar; 36(11):3331-5. PubMed ID: 9116011
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of activated protein C by platelets.
Jane SM; Mitchell CA; Hau L; Salem HH
J Clin Invest; 1989 Jan; 83(1):222-6. PubMed ID: 2910909
[TBL] [Abstract][Full Text] [Related]
12. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
Nishioka J; Ido M; Hayashi T; Suzuki K
Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
[TBL] [Abstract][Full Text] [Related]
13. Plasma factor V activation is prevented by activated protein C in the presence of phospholipid vesicles, not platelets.
Solymoss S; Nguyen KT
Thromb Haemost; 1993 Feb; 69(2):124-9. PubMed ID: 8456424
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of coagulometric assays in the assessment of protein C anticoagulant activity; variable sensitivity of commercial APTT reagents to the cofactor effect of protein S.
D'Angelo SV; Gilardoni F; D'Angelo A
Thromb Haemost; 1989 Nov; 62(3):861-7. PubMed ID: 2531939
[TBL] [Abstract][Full Text] [Related]
15. Protein C.
Esmon CT
Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
[TBL] [Abstract][Full Text] [Related]
16. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
17. Phospholipid-bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivation.
Váradi K; Siekmann J; Turecek PL; Schwarz HP; Marder VJ
Thromb Haemost; 1999 Dec; 82(6):1673-9. PubMed ID: 10613654
[TBL] [Abstract][Full Text] [Related]
18. The anticoagulant properties of a modified form of protein S.
Mitchell CA; Kelemen SM; Salem HH
Thromb Haemost; 1988 Oct; 60(2):298-304. PubMed ID: 2975408
[TBL] [Abstract][Full Text] [Related]
19. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
Evenäs P; García de Frutos P; Nicolaes GA; Dahlbäck B
Thromb Haemost; 2000 Aug; 84(2):271-7. PubMed ID: 10959700
[TBL] [Abstract][Full Text] [Related]
20. Functional and binding studies of the roles of prothrombin and beta 2-glycoprotein I in the expression of lupus anticoagulant activity.
Permpikul P; Rao LV; Rapaport SI
Blood; 1994 May; 83(10):2878-92. PubMed ID: 8180383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
